Hyperfractionated radiation therapy with or without concurrent chemotherapy in stage III non-small cell lung cancer (NSCLC): Single-institution experience in 600 patients

被引：0

作者：

Jeremic, B. ^{[1
]}

Milicic, B. ^{[2
]}

机构：

[1] IAEA, A-1400 Vienna, Austria

[2] Univ Hosp, Kragujevac, Serbia

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2008.06.1368

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S437 / S437

页数：1

共 50 条

[1] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Branislav Jeremić
Biljana Miličić
Slobodan Milisavljevic
[J]. Clinical and Translational Oncology, 2012, 14 : 613 - 618
[2] EVOLUTION OF CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL CELL LUNG CANCER (NSCLC). SINGLE INSTITUTION EXPERIENCE IN 600 PATIENTS
Jeremic, B.
[J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S343 - S344
[3] EVOLUTION OF CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL CELL LUNG CANCER (NSCLC). SINGLE INSTITUTION EXPERIENCE IN 600 PATIENTS
Jeremic, B.
Milicic, B.
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 643 - 643
[4] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Jeremic, Branislav
Milicic, Biljana
Milisavljevic, Slobodan
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 613 - 618
[5] CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL-CELL LUNG CANCER: SINGLE INSTITUTION EXPERIENCE WITH 600 PATIENTS
Jeremic, Branislav
Milicic, Biljana
Milisavljevic, Slobodan
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1157 - 1163
[6] Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer
Adelstein, DJ
Rice, TW
Rybicki, LA
Greskovich, JF
Ciezki, JP
Carroll, MA
DeCamp, MM
[J]. LUNG CANCER, 2002, 36 (02) : 167 - 174
[7] Clinical Prognostic Factors in Patients with Locally Advanced (Stage III) Non-small Cell Lung Cancer Treated with Concurrent Hyperfractionated Radiation Therapy and Chemotherapy
Jeremic, B.
Milicic, B.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S509 - S509
[8] Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer
Lochrin, C
Goss, G
Stewart, DJ
Cross, P
Agboola, O
Dahrouge, S
Tomiak, E
Evans, WK
[J]. LUNG CANCER, 1999, 23 (01) : 19 - 30
[9] Outcomes of Hypofractionated Radiation Therapy (HFRT) with Concurrent Chemotherapy in Patients with Stage III Non Small Cell Lung Cancer (NSCLC)
Shepherd, A.
Gelblum, D.
Wu, A.
Rimner, A.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S661 - S662
[10] A single institution experience on concurrent chemoradiotherapy (CCT) in non-small cell lung cancer (NSCLC)
Choudhury, Mahbuba
MuthuKumar, Dakshinamoorthy
[J]. LUNG CANCER, 2021, 156 : S55 - S55

← 1 2 3 4 5 →